Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Jeffrey, Sprouse"'
Autor:
Samantha T. Reyes, Robert M. J. Deacon, Scarlett G. Guo, Francisco J. Altimiras, Jessa B. Castillo, Berend van der Wildt, Aimara P. Morales, Jun Hyung Park, Daniel Klamer, Jarrett Rosenberg, Lindsay M. Oberman, Nell Rebowe, Jeffrey Sprouse, Christopher U. Missling, Christopher R. McCurdy, Patricia Cogram, Walter E. Kaufmann, Frederick T. Chin
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Fragile X syndrome (FXS), a disorder of synaptic development and function, is the most prevalent genetic form of intellectual disability and autism spectrum disorder. FXS mouse models display clinically-relevant phenotypes, such as increased
Externí odkaz:
https://doaj.org/article/3fe726770d9a49e4a8f47d5b5a43daca
Autor:
Patricia Cogram, Robert M. J. Deacon, Daniel Klamer, Nell Rebowe, Jeffrey Sprouse, Samantha T. Reyes, Christopher U. Missling, Walter E. Kaufmann
Publikováno v:
American journal of medical genetics. Part AREFERENCES. 188(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa27f9d6ff88dad7a2e96f6535d442e7
https://pubmed.ncbi.nlm.nih.gov/35661397
https://pubmed.ncbi.nlm.nih.gov/35661397
Autor:
Berend van der Wildt, Daniel Klamer, Samantha T. Reyes, Jeffrey Sprouse, Robert M. J. Deacon, Nell Rebowe, Walter E. Kaufmann, Aimara P. Morales, Lindsay M. Oberman, Jarrett Rosenberg, Frederick T. Chin, Jun Hyung Park, Scarlett G. Guo, Francisco Altimiras, Christopher U. Missling, Jessa B. Castillo, Patricia Cogram, Christopher R. McCurdy
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports
Scientific Reports
Fragile X syndrome (FXS), a disorder of synaptic development and function, is the most prevalent genetic form of intellectual disability and autism spectrum disorder. FXS mouse models display clinically-relevant phenotypes, such as increased anxiety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c948229589818defff7cde088fec673
https://doi.org/10.1038/s41598-021-94079-7
https://doi.org/10.1038/s41598-021-94079-7
Autor:
Jessa B. Castillo, Berend van de Wildt, Nell Robowe, Scarlett G. Guo, Samantha T. Reyes, Jeffrey Sprouse, Jun Hyung Park, Christopher U. Missling, Aimara P. Morales, Frederick T. Chin
Publikováno v:
Alzheimer's & Dementia. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a57b49b2866eef0ad35e153d7cbb2184
https://doi.org/10.1016/j.jalz.2018.07.084
https://doi.org/10.1016/j.jalz.2018.07.084
Autor:
Joost H.A. Folgering, Anne W. Schmidt, Jeffrey Sprouse, Anatoliy V. Gladkevich, Thomas I. F. H. Cremers, Johan A. den Boer, Marieke C. G. van der Hart, Ben H.C. Westerink, Fokko J. Bosker
Publikováno v:
Journal of Neurochemistry, 108(5), 1126-1135. Blackwell Publishing Ltd
Both microdialysis and electrophysiology were used to investigate whether another serotonin (5-HT) receptor subtype next to the 5-HT(1A) autoreceptor is involved in the acute effects of a selective serotonin reuptake inhibitor on 5-HT neuronal activi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43e3970a9e3e1de41f2fb6d67b1d2eea
https://doi.org/10.1111/j.1471-4159.2008.05850.x
https://doi.org/10.1111/j.1471-4159.2008.05850.x
Publikováno v:
Biological Psychiatry. 60:896-899
Background The documented ability of serotonin (5-HT) to directly modulate circadian rhythms prompted interest in a similar role for therapeutic agents that readily enhance 5-HT neurotransmission, namely the selective serotonin reuptake inhibitors (S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9e7cac0b7bd72ab5c6fe1fd47e8bdf8
https://doi.org/10.1016/j.biopsych.2006.03.003
https://doi.org/10.1016/j.biopsych.2006.03.003
Publikováno v:
Journal of Biological Rhythms. 20:122-131
In vitro neuronal recordings in the SCN have clearly documented shifts in the peak of unit activity following the application of serotonergic agents, and yet selectivity issues with these very tools have limited progress in establishing the precise r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd105226cf00d72f672cc32d4ed79c9d
https://doi.org/10.1177/0748730404273432
https://doi.org/10.1177/0748730404273432
Publikováno v:
Neuropharmacology. 46:52-62
Neurons in the suprachiasmatic nucleus (SCN), the site of the endogenous biological clock in mammals, fire spontaneously, peaking in firing rate near ZT6 or at the midpoint of the light phase in a 12:12 light-dark cycle. In rat hypothalamic slices, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a39c68944e03362c0cc40516723ca2a1
https://doi.org/10.1016/j.neuropharm.2003.08.007
https://doi.org/10.1016/j.neuropharm.2003.08.007
Publikováno v:
Synapse. 54:111-118
Spontaneous firing rates of neurons in the suprachiasmatic nuclei (SCN) follow a consistent pattern, peaking near the midpoint of the light phase in a 12:12 light/dark schedule, and repeating this brief period of increased activity in subsequent circ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcc59ba847ea04db4c7c7d8b6513da37
https://doi.org/10.1002/syn.20070
https://doi.org/10.1002/syn.20070
Publikováno v:
Neuropsychopharmacology. 21:622-631
Ziprasidone is a novel antipsychotic agent which binds with high affinity to 5-HT1A receptors (Ki = 3.4 nM), in addition to 5-HT1D, 5-HT2, and D2 sites. While it is an antagonist at these latter receptors, ziprasidone behaves as a 5-HT1A agonist in v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c51d395820cb4d4bf766487fc12e5352
https://doi.org/10.1016/s0893-133x(99)00057-3
https://doi.org/10.1016/s0893-133x(99)00057-3